title: Anemia management in CKD patients in the era of new US Food and Drug Administration recommendations on the use of erythropoiesis-stimulating agents.
authors: James S
authors: JS
authors: Kaufman
mesh_terms: D000740:Anemia / Q000097:blood* / Q000188:drug therapy*; D000068256:Darbepoetin alfa; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006397:Hematinics / Q000494:pharmacology* / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D008297:Male; D051436:Renal Insufficiency, Chronic / Q000097:blood*
chemical_list: D006397:Hematinics; D006454:Hemoglobins; D004921:Erythropoietin; D000068256:Darbepoetin alfa